MedPath
NMPA Approval

Doxazosin Mesylate Extended Release Tablets

国药准字H20233967

July 25, 2023

Drug Information

甲磺酸多沙唑嗪缓释片

片剂

4mg(按C₂₃H₂₅N₅O₅计)

化学药品

July 25, 2023

Company Information

Applicant Company

江西省赣州经济技术开发区凤凰路116号

Manufacturing Company

江西省赣州经济技术开发区凤凰路116号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.